LABCORP HOLDINGS INC. Proceeds from Long-Term Debt Issued
LABCORP HOLDINGS INC. (LH) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2023-02-28
- LABCORP HOLDINGS INC. proceeds from issuance of long-term debt for the quarter ending 2018-12-31 was $0.00.
- LABCORP HOLDINGS INC. proceeds from issuance of long-term debt for the quarter ending 2017-12-31 was $0.00.
- LABCORP HOLDINGS INC. proceeds from issuance of long-term debt for the quarter ending 2016-12-31 was $0.00.
- LABCORP HOLDINGS INC. proceeds from issuance of long-term debt for the quarter ending 2016-09-30 was $0.00.
- LABCORP HOLDINGS INC. proceeds from issuance of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- LABCORP HOLDINGS INC. proceeds from issuance of long-term debt for fiscal 2021 was $1.00B.
- LABCORP HOLDINGS INC. proceeds from issuance of long-term debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- LABCORP HOLDINGS INC. proceeds from issuance of long-term debt for fiscal 2019 was $1.05B.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2021-12-31 | $1.00B 10-K · filed 2023-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $1.05B 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $0.00 10-Q · filed 2018-10-30 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.20B 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $1.20B 10-Q · filed 2018-10-30 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2016-10-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $0.00 10-Q · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-06 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $2.90B 10-K · filed 2018-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $0.00 derived: sum of 2 quarters · filed 2016-10-28 | $2.90B 10-Q · filed 2016-10-28 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $2.90B 10-Q · filed 2016-07-29 | ||
| 2015-03-31 | $2.90B 10-Q · filed 2016-05-06 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-03-01 | |||
| 2014-03-31 | $0.00 10-K · filed 2017-02-27 | |||
| 2013-12-31 | $700.00M 10-K · filed 2016-03-01 | |||
| 2012-12-31 | $1.00B 10-K · filed 2015-02-26 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 | |||
| 2010-12-31 | $925.00M 10-K · filed 2013-02-26 | |||
| 2009-12-31 | $0.00 10-K · filed 2012-02-24 | |||
| 2008-12-31 | $0.00 10-K/A · filed 2011-03-07 | |||
| 2007-12-31 | $500.00M 10-K · filed 2010-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |